DCPH - Deciphera Pharmaceuticals LLC - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Deciphera Pharmaceuticals LLC's activity chart (see below) currently has 135 price targets and 119 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 55.35% with an average time for these price targets to be met of 184.78 days.

Most recent stock forecast was given by BRADLEY CANINO from STIFEL on 10-May-2024. First documented stock forecast 23-Oct-2017.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 31-Oct-2023

$23

$-2.59 (-10.12%)

$23

2 years 4 months 21 days ago
(10-May-2024)

6/9 (66.67%)

$-2.36 (-9.31%)

90

Sell Since 04-Jan-2023

$26

$0.41 (1.60%)

2 years 5 months 1 days ago
(30-Apr-2024)

3/9 (33.33%)

$0.73 (2.89%)

235

Buy Since 17-Sep-2018

$22

2 years 5 months 1 days ago
(30-Apr-2024)

2/3 (66.67%)

$2.24 (11.34%)

67

Hold Since 29-Apr-2024

$23

2 years 5 months 2 days ago
(29-Apr-2024)

4/7 (57.14%)

$8.58 (59.50%)

352

Buy Since 29-Apr-2024

$16

$-9.59 (-37.48%)

2 years 5 months 2 days ago
(29-Apr-2024)

1/4 (25%)

$-9.28 (-36.71%)

44

Show more analysts

Please expand the browser size to see the chart

What is DCPH (Deciphera Pharmaceuticals LLC) average time for price targets to be met?

On average it took 185 days for the stock forecasts to be reached, with an average price target met ratio of 55.35%.

Which analyst most recently updated their price target on DCPH (Deciphera Pharmaceuticals LLC)?

Bradley Canino

Which analyst has the most public recommendations on DCPH (Deciphera Pharmaceuticals LLC)?

Bradley Canino works at GUGGENHEIM and has 12 price targets and 10 ratings on DCPH

Which analyst is the currently most bullish on DCPH (Deciphera Pharmaceuticals LLC)?

Konstantinos Aprilakis with the highest potential upside of $49.41

Which analyst is the currently most reserved on DCPH (Deciphera Pharmaceuticals LLC)?

Soumit Roy with the lowest potential downside of -$9.59
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?